| Title : Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities - Hirmas_2023_J.Nucl.Med_64_711 |
| Author(s) : Hirmas N , Hamacher R , Sraieb M , Ingenwerth M , Kessler L , Pabst KM , Barbato F , Lueckerath K , Kasper S , Nader M , Schildhaus HU , Kesch C , von Tresckow B , Hanoun C , Hautzel H , Aigner C , Glas M , Stuschke M , Kummel S , Harter P , Lugnier C , Uhl W , Niedergethmann M , Hadaschik B , Grunwald V , Siveke JT , Herrmann K , Fendler WP |
| Ref : J Nucl Med , 64 :711 , 2023 |
| Abstract : |
| PubMedSearch : Hirmas_2023_J.Nucl.Med_64_711 |
| PubMedID: 36581374 |
| Title : FAP imaging in rare cancer entities-first clinical experience in a broad spectrum of malignancies - Dendl_2022_Eur.J.Nucl.Med.Mol.Imaging_49_721 |
| Author(s) : Dendl K , Finck R , Giesel FL , Kratochwil C , Lindner T , Mier W , Cardinale J , Kesch C , Rohrich M , Rathke H , Gampp H , Ristau J , Adeberg S , Jager D , Debus J , Haberkorn U , Koerber SA |
| Ref : Eur J Nucl Med Mol Imaging , 49 :721 , 2022 |
| Abstract : |
| PubMedSearch : Dendl_2022_Eur.J.Nucl.Med.Mol.Imaging_49_721 |
| PubMedID: 34342669 |
| Title : High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics - Kesch_2021_Eur.J.Nucl.Med.Mol.Imaging_49_385 |
| Author(s) : Kesch C , Yirga L , Dendl K , Handke A , Darr C , Krafft U , Radtke JP , Tschirdewahn S , Szarvas T , Fazli L , Gleave M , Giesel FL , Haberkorn U , Hadaschik B |
| Ref : Eur J Nucl Med Mol Imaging , 49 :385 , 2021 |
| Abstract : |
| PubMedSearch : Kesch_2021_Eur.J.Nucl.Med.Mol.Imaging_49_385 |
| PubMedID: 34226953 |